Case Discussion: Early Detection of Prostate Cancer 2023
Thomas E. Keane, MD, discusses the management options for a 63-year-old patient with increasing PSA levels. He explores the significance of obtaining medical history and PSA history, ordering tests or an MRI, performing a biopsy, or sending the patient home.
Watch our Editor-in-Chief's latest presentation on early detection here: https://grandroundsinurology.com/early-detection-of-prostate-cancer-navigating-the-challenges-in-2023/
Видео Case Discussion: Early Detection of Prostate Cancer 2023 канала Grand Rounds in Urology
Watch our Editor-in-Chief's latest presentation on early detection here: https://grandroundsinurology.com/early-detection-of-prostate-cancer-navigating-the-challenges-in-2023/
Видео Case Discussion: Early Detection of Prostate Cancer 2023 канала Grand Rounds in Urology
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Telehealth in Urology 2024NMIBC Post-FDA Approval of New DrugsTestosterone Update on Oral ProductsNew Horizons in Robotic Reconstructive UrologyRecurrent UTIs: Ask the GuidelineEarly Detection of Prostate Cancer: Navigating the ChallengesPSA Screening in 2023Point-Counterpoint: Erectile Dysfunction After Local Therapies: PDE5 Inhibitors and Penile Rehab–ConPoint-Counterpoint: Erectile Dysfunction After Local Therapies: PDE5 Inhibitors and Penile Rehab–PromCRPC - Results from the Triton 3 StudyGarnick - Review of the New Standard in Treatment and Global IssuesChanging Paradigm in the Diagnosis Band Management of Erectile DysfunctionDECIPHER: Predicting Prognosis and Assisting Treatment Decisions for Prostate CancerMR Fusion Targeted Therapy: Emerging Management for Localized Prostate Cancer?Metastatic Castration Resistant Prostate Cancer (mCRPC) – Inroads in Improved OutcomesForward Progress in Molecular Markers for Prostate CancerSelecting Candidates for Focal TherapyPatient Selection in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Prioritizing the Optimal Therapy for T1 Bladder Cancer: Using the Old and NewMale Mortality & Men’s Health Issues: Barriers, Testosterone, PDE5 Therapy, and GLP1 Agonist Therapy